JP4970442B2 - Whitening agent - Google Patents

Whitening agent Download PDF

Info

Publication number
JP4970442B2
JP4970442B2 JP2008522268A JP2008522268A JP4970442B2 JP 4970442 B2 JP4970442 B2 JP 4970442B2 JP 2008522268 A JP2008522268 A JP 2008522268A JP 2008522268 A JP2008522268 A JP 2008522268A JP 4970442 B2 JP4970442 B2 JP 4970442B2
Authority
JP
Japan
Prior art keywords
added
extract
betel
mass
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2008522268A
Other languages
Japanese (ja)
Other versions
JPWO2008001465A1 (en
Inventor
理歌 根岸
雅樹 荒島
浩子 吉田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noevir Co Ltd
Original Assignee
Noevir Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noevir Co Ltd filed Critical Noevir Co Ltd
Publication of JPWO2008001465A1 publication Critical patent/JPWO2008001465A1/en
Application granted granted Critical
Publication of JP4970442B2 publication Critical patent/JP4970442B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

本発明は、天然由来成分を有効成分とする保湿剤、抗老化剤、美白剤及び抗酸化剤に関する。   The present invention relates to a moisturizing agent, an anti-aging agent, a whitening agent and an antioxidant containing natural ingredients as active ingredients.

加齢、紫外線、ストレスなどによるシワ、シミ、皮膚の弾性低下といった皮膚症状の要因として、乾燥、細胞機能低下、紫外線によるメラニン産生や色素沈着、真皮マトリックス成分の減少や変性、紫外線等による細胞の酸化傷害などが挙げられる。このような皮膚症状を防止・改善するために、様々な有効成分の検索及び配合検討が従来なされてきた。   Causes of skin symptoms such as aging, ultraviolet rays, stress, wrinkles, stains, skin elasticity decrease, dryness, decreased cellular function, melanin production and pigmentation due to ultraviolet rays, decrease or degeneration of dermal matrix components, ultraviolet rays, etc. Examples include oxidative damage. In order to prevent and ameliorate such skin symptoms, search for various active ingredients and formulation studies have been conventionally conducted.

特に天然由来成分は、様々な薬理作用や美容効果を有することが知られ、これまでにも数多くの植物や菌類などの抽出物の皮膚外用剤への応用が検討されてきた。例えば、抗老化剤としてポンカンのエッセンス(特許文献1参照)、美白剤として白鶴霊芝の水及び/又は有機溶媒抽出物(特許文献2参照)、抗酸化剤としてサルオガセ科サルオガセ属植物の抽出物(特許文献3参照)等が知られている。   In particular, naturally-derived components are known to have various pharmacological and cosmetic effects, and so far, applications of extracts such as plants and fungi to skin external preparations have been studied. For example, the essence of Ponkan as an anti-aging agent (see Patent Document 1), a water and / or organic solvent extract of Hakutsuru Reishi as a whitening agent (see Patent Document 2), and an extract of the plant of the genus Sarogase as an antioxidant. (See Patent Document 3) and the like are known.

また、植物の抽出物としてキンマエキスを配合した皮膚外用剤が知られている(例えば、特許文献4,5参照)。しかしながら、キンマエキスを、保湿剤、抗老化剤、美白剤、抗酸化剤として検討した従来技術、及びキンマエキスの保湿作用、抗老化作用、美白作用及び抗酸化作用について検討した報告は存在しない。
特開2001−131045号公報 特開2003−89630号公報 特開平10−182413号公報 特開平6−336417号公報 特開平10−45540号公報
Moreover, the skin external preparation which mix | blended the betel extract as a plant extract is known (for example, refer patent document 4, 5). However, there are no reports on the investigation of the betel extract as a moisturizer, anti-aging agent, whitening agent, antioxidant, and the moisturizing action, anti-aging action, whitening action and antioxidant action of betel extract.
JP 2001-131045 A JP 2003-89630 A Japanese Patent Laid-Open No. 10-182413 JP-A-6-336417 Japanese Patent Laid-Open No. 10-45540

天然由来成分の中には未だその効果が知られていないものも数多く存在し、優れた保湿作用、抗老化作用、美白作用及び抗酸化作用などを有する有効成分の開発が期待されていた。本発明は、このような有効成分を見出すためになされたものであり、皮膚外用剤や飲食品として応用が可能な保湿剤、抗老化剤、美白剤及び抗酸化剤を提供することを目的とする。   There are many naturally derived ingredients whose effects are not yet known, and the development of effective ingredients having excellent moisturizing action, anti-aging action, whitening action and antioxidant action has been expected. The present invention was made in order to find such an active ingredient, and aims to provide a moisturizer, an anti-aging agent, a whitening agent, and an antioxidant that can be applied as an external preparation for skin and food and drink. To do.

本発明者らは、皮膚外用剤や飲食品に応用が可能な保湿剤、抗老化剤、美白剤及び抗酸化剤を見出すために、天然由来の種々の成分について検討を行った。その結果、キンマの抽出物に優れた保湿作用、抗老化作用、美白作用及び抗酸化作用を見出し、さらに検討を重ね、本発明を完成するに至った。すなわち、本発明は、キンマの抽出物を有効成分とする保湿剤、抗老化剤、美白剤及び抗酸化剤を提供するものである。ここでいうキンマの抽出物を有効成分とする保湿剤、抗老化剤、美白剤及び抗酸化剤とは、製造過程においてキンマの抽出物を基剤に配合する場合と、キンマをそのまま基剤に配合する場合とを含む。   In order to find a moisturizer, an anti-aging agent, a whitening agent, and an antioxidant that can be applied to external preparations for skin and foods and drinks, the present inventors have studied various components derived from nature. As a result, they have found an excellent moisturizing action, anti-aging action, whitening action and antioxidant action in betel extract, and have further studied to complete the present invention. That is, the present invention provides a moisturizer, an anti-aging agent, a whitening agent, and an antioxidant containing a betel extract as an active ingredient. The moisturizer, anti-aging agent, whitening agent and antioxidant used as the active ingredient here are the case where the bean extract is added to the base during the production process, and the bean is used as the base. Including the case of blending.

本発明によれば、優れた効果を有する保湿剤、抗老化剤、美白剤及び抗酸化剤を提供することができ、これらを皮膚外用剤や飲食品等の組成物に配合することにより、シワ、タルミ、肌のハリ、シミ、クスミといった種々の皮膚症状の防止や改善に優れた作用を奏する様々な組成物を提供することができる。   According to the present invention, it is possible to provide a moisturizing agent, an anti-aging agent, a whitening agent and an antioxidant having an excellent effect, and by adding these to a composition such as a skin external preparation or food and drink, It is possible to provide various compositions that have an excellent effect in preventing and improving various skin symptoms such as talmi, skin firmness, stains, and kusumi.

本発明の実施に用いられる植物であるキンマ(学名:Piper betle)は、マレーシア地域原産のコショウ科コショウ属に属する常緑つる性植物である。   Betel (Scientific name: Piper betle), which is a plant used in the practice of the present invention, is an evergreen vine that belongs to the genus Pepperaceae, native to the Malaysian region.

キンマを使用する際は、そのまま粉砕して使用することもできるが、抽出物を用いるとよい。抽出には、キンマの葉、根、種子、茎などのいずれの部位を用いても構わないが、簡便に利用するには、葉、茎、種子を用いるとよく、有効性の点からは葉や茎を用いるとよい。抽出の際は、生のまま用いてもよいが、抽出効率を考えると、細切、乾燥、粉砕等の処理を行った後に抽出を行うことが好ましい。抽出は、抽出溶媒に浸漬するか、超臨界流体や亜臨界流体を用いた抽出方法でも行うことができる。抽出効率を上げるため、撹拌や抽出溶媒中でホモジナイズしてもよい。抽出温度としては、5℃程度から抽出溶媒の沸点以下の範囲の温度とするのが適切である。抽出時間は抽出溶媒の種類や抽出温度によって異なるが、例えば1時間〜14日間程度とすることができる。   When using the betel, it can be used by pulverizing as it is, but it is preferable to use an extract. For extraction, any part such as betel leaves, roots, seeds, and stems may be used, but for convenient use, leaves, stems, and seeds may be used. Or stems. In the extraction, it may be used as it is, but considering the extraction efficiency, it is preferable to perform the extraction after performing processing such as shredding, drying, and pulverization. The extraction can be performed by immersing in an extraction solvent or by an extraction method using a supercritical fluid or a subcritical fluid. In order to increase the extraction efficiency, the mixture may be homogenized in stirring or an extraction solvent. The extraction temperature is suitably in the range of about 5 ° C. to the boiling point of the extraction solvent. The extraction time varies depending on the type of extraction solvent and the extraction temperature, but can be, for example, about 1 hour to 14 days.

抽出溶媒として、メタノール、エタノール、プロパノール及びイソプロパノール等の低級アルコール、1、3−ブチレングリコール、プロピレングリコール、ジプロピレングリコール及びグリセリン等の多価アルコール、エチルエーテル及びプロピルエーテル等のエーテル類、酢酸ブチル及び酢酸エチル等のエステル類、アセトン及びエチルメチルケトン等のケトン類、水などの溶媒を用いることができ、これらより1種又は2種以上を選択して用いる。また、生理食塩水、リン酸緩衝液、リン酸緩衝生理食塩水等を用いてもよい。さらに、水や二酸化炭素、エチレン、プロピレン、エタノール、メタノール、アンモニアなどの1種又は2種以上の超臨界流体や亜臨界流体を用いてもよい。   As extraction solvents, lower alcohols such as methanol, ethanol, propanol and isopropanol, polyhydric alcohols such as 1,3-butylene glycol, propylene glycol, dipropylene glycol and glycerin, ethers such as ethyl ether and propyl ether, butyl acetate and Esters such as ethyl acetate, ketones such as acetone and ethyl methyl ketone, and solvents such as water can be used, and one or more of these are selected and used. Further, physiological saline, phosphate buffer, phosphate buffered saline, or the like may be used. Furthermore, you may use 1 type, or 2 or more types of supercritical fluids and subcritical fluids, such as water, a carbon dioxide, ethylene, propylene, ethanol, methanol, ammonia.

キンマの上記溶媒による抽出物は、そのままでも使用することができるが、濃縮し、又は濃縮乾固し、これを水や極性溶媒に再度溶解して使用することもできる。また、生理作用を損なわない範囲で、抽出物を脱色、脱臭、脱塩等の精製処理やカラムクロマトグラフィー等による分画処理を施し用いてもよい。キンマの前記抽出物、その処理物及びその分画物は、各処理及び分画後に凍結乾燥し、用時に溶媒に溶解して用いることもできる。   The extract of betel with the above solvent can be used as it is, but it can also be used by concentrating or concentrating to dryness, and dissolving it again in water or a polar solvent. In addition, the extract may be used after subjecting the extract to purification treatment such as decolorization, deodorization, and desalting, and fractionation treatment such as column chromatography. The extract of betel, its treated product and its fraction can be freeze-dried after each treatment and fractionation and dissolved in a solvent before use.

キンマの抽出物は、優れた保湿作用、抗老化作用、美白作用及び抗酸化作用を有し、保湿剤、抗老化剤、美白剤、抗酸化剤及び皮膚外用剤として利用することができる。また、キンマの抽出物を有効成分とする保湿剤、抗老化剤、美白剤及び抗酸化剤は、皮膚に外用するだけではなく、毛髪に利用することや経口摂取も可能であり、食品、飲料、あるいは医薬品などにも応用することが可能である。   The extract of betel has excellent moisturizing action, anti-aging action, whitening action and antioxidant action, and can be used as a moisturizing agent, anti-aging agent, whitening agent, antioxidant and external preparation for skin. In addition, moisturizers, anti-aging agents, whitening agents and antioxidants containing betel extract as an active ingredient can be used not only for the skin but also for hair and can be taken orally. Or it can be applied to pharmaceuticals.

キンマの抽出物を有効成分とする保湿剤は、皮膚や毛髪に対して優れた保湿作用を発揮し、特に皮膚に対する保湿効果が高い。   A moisturizing agent containing a betel extract as an active ingredient exhibits an excellent moisturizing effect on the skin and hair, and has a particularly high moisturizing effect on the skin.

キンマの抽出物を有効成分とする抗老化剤は、種々の細胞に対して優れた賦活作用を発揮するが、特に真皮線維芽細胞に対して優れた効果を発揮する。   An anti-aging agent comprising a betel extract as an active ingredient exerts an excellent activation effect on various cells, but particularly exhibits an excellent effect on dermal fibroblasts.

キンマの抽出物を有効成分とする美白剤は、シミ・ソバカスといった色素沈着症状の改善に効果を発揮し、特にチロシナーゼ活性阻害に基づくメラニンの産生抑制に対して優れた効果を発揮する。   A whitening agent containing an extract of betel as an active ingredient is effective in improving pigmentation symptoms such as spots and freckles, and in particular, is excellent in suppressing melanin production based on inhibition of tyrosinase activity.

キンマの抽出物を有効成分とする抗酸化剤は、優れた抗酸化作用を発揮するが、特にフリーラジカル消去作用、スーパーオキサイドアニオン消去作用に優れた効果を発揮する。   Antioxidants containing betel extract as an active ingredient exhibit an excellent antioxidant effect, but particularly exhibit an excellent effect on free radical scavenging action and superoxide anion scavenging action.

また、キンマの抽出物を皮膚外用剤に配合することにより、シワ、タルミ、肌のハリ、シミ、クスミ、乾燥、小じわ等の皮膚症状の防止・改善に優れた効果を発揮する皮膚外用剤を得ることができ、老化防止改善用皮膚外用剤や美白用皮膚外用剤としても用いることができる。さらに、キンマの抽出物は、美容、健康維持、又は栄養補給を目的とするような食品や飲料にも用いることもできる。   In addition, by adding the extract of betel to a skin external preparation, a skin external preparation that exhibits an excellent effect in preventing and improving skin symptoms such as wrinkles, talmi, skin firmness, stains, kusumi, dryness, fine lines, etc. It can be obtained, and can also be used as a skin external preparation for improving aging prevention and a skin external preparation for whitening. Furthermore, the extract of betel can also be used for foods and beverages for the purpose of beauty, health maintenance or nutritional supplementation.

キンマの抽出物を皮膚外用剤に配合する際の配合量は、皮膚外用剤の種類や使用目的等によって調整することができるが、効果や安定性などの点から、全量に対して0.0001〜50.0質量%が好ましく、より好ましくは、0.001〜25.0質量%である。   The amount of betel extract to be added to the skin external preparation can be adjusted according to the type of skin external preparation, purpose of use, etc., but from the viewpoint of effect and stability, the total amount is 0.0001. -50.0 mass% is preferable, More preferably, it is 0.001-25.0 mass%.

キンマの抽出物を配合する皮膚外用剤の剤型は任意であり、例えば、ローションなどの可溶化系、クリームや乳液などの乳化系、カラミンローション等の分散系として提供することができる。さらに、噴射剤と共に充填したエアゾール、軟膏剤、粉末、顆粒などの種々の剤型で提供することもできる。   The dosage form of the external preparation for skin containing the extract of betel is arbitrary, and can be provided as a solubilizing system such as lotion, an emulsifying system such as cream or milky lotion, or a dispersing system such as calamine lotion. Furthermore, it can also be provided in various dosage forms such as aerosols, ointments, powders and granules filled with a propellant.

なお、キンマの抽出物を配合する皮膚外用剤には、キンマの抽出物の他に、必要に応じて、通常医薬品、医薬部外品、皮膚化粧料、毛髪用化粧料及び洗浄料に配合される、油性成分、保湿剤、粉体、色素、乳化剤、可溶化剤、洗浄剤、紫外線吸収剤、増粘剤、薬剤、香料、樹脂、防菌防黴剤、アルコール類等を適宜配合することができる。また、本発明の効果を損なわない範囲において、他の保湿剤、抗老化剤、美白剤、抗酸化剤との併用も可能である。   In addition to the betel extract, the topical skin preparation containing betel extract is usually incorporated into pharmaceuticals, quasi drugs, skin cosmetics, hair cosmetics, and cleansing agents as needed. Oily ingredients, moisturizers, powders, pigments, emulsifiers, solubilizers, detergents, UV absorbers, thickeners, drugs, fragrances, resins, antibacterial and antifungal agents, alcohols, etc. Can do. Moreover, in the range which does not impair the effect of this invention, combined use with another moisturizer, an anti-aging agent, a whitening agent, and an antioxidant is also possible.

以下に、キンマの抽出物の製造例、各作用を評価するための試験についてさらに詳細に説明するが、本発明の技術的範囲はこれによってなんら限定されるものではない。   Below, the manufacture example of a betel extract and the test for evaluating each effect | action are demonstrated in detail, However, The technical scope of this invention is not limited at all by this.

[製造例1]
キンマの葉を乾燥させて粉砕し、かかる粉砕物の重量の20倍量の50質量%エタノール水溶液を加え、室温にて撹拌しながら2時間抽出した。抽出液をろ過して回収し、減圧濃縮後、凍結乾燥を行って製造例1のキンマ抽出物を得た。
[Production Example 1]
The betel leaf was dried and pulverized, and a 50 mass% aqueous ethanol solution 20 times the weight of the pulverized product was added, followed by extraction for 2 hours while stirring at room temperature. The extract was collected by filtration, concentrated under reduced pressure, and then freeze-dried to obtain a betel extract of Production Example 1.

[製造例2]
キンマの葉を乾燥させて粉砕し、かかる粉砕物の重量の20倍量の精製水を加えてオートグレーブにて20分間、120度に加温して抽出した。高温を維持した状態で、吸引ろ過により不要物を取り除いた後、凍結乾燥を行って製造例2のキンマ抽出物を得た。
[Production Example 2]
Betel leaves were dried and pulverized, purified water of 20 times the weight of the pulverized product was added, and the mixture was extracted by heating at 120 ° C. for 20 minutes in an autograve. In a state where the high temperature was maintained, unnecessary substances were removed by suction filtration, and then lyophilized to obtain a betel extract of Production Example 2.

[作用評価]
1.ヒト真皮線維芽細胞賦活評価
まず、キンマ抽出物のヒト真皮線維芽細胞賦活評価を以下に示す方法により行った。試料として、製造例2により製造したキンマ抽出物を用いた。
[Evaluation of action]
1. Evaluation of human dermal fibroblast activation First, human dermal fibroblast activation evaluation of betel extract was performed by the following method. As a sample, the betel extract produced in Production Example 2 was used.

正常ヒト真皮線維芽細胞を1ウェル当たり2.0×10個となるように96穴マイクロプレートに播種した。播種培地には、ダルベッコ改変イーグル培地(DMEM)に1質量%のウシ胎児血清(FBS)を添加したものを用いた。24時間後、試料溶液を各濃度となるように添加した1質量%FBS添加DMEM培地に交換し、さらに48時間培養した。上清を除いた後、3−(4,5−ジメチル−2−チアゾリル)−2,5−ジフェニルテトラゾリウムブロミド(MTT)を400μg/mL含有する培地を細胞に添加して約2時間培養した。最後に、テトラゾリウム環の開環により生じるフォルマザンを2−プロパノールにて抽出し、マイクロプレートリーダーにて550nm、650nmの吸光度を測定し、両測定値の差を用いて細胞賦活作用を評価した。評価では、試料溶液を含む培地の他に、ネガティブコントロールとして1質量%FBS添加DMEM培地を、ポジティブコントロールとして5質量%FBS添加DMEM培地を用いた。評価結果をネガティブコントロールにおける細胞賦活作用を100とした相対値にて表1に示す。Normal human dermal fibroblasts were seeded in a 96-well microplate at 2.0 × 10 4 cells per well. As the seeding medium, Dulbecco's modified Eagle medium (DMEM) to which 1% by mass of fetal bovine serum (FBS) was added was used. After 24 hours, the sample solution was replaced with 1% by mass FBS-added DMEM medium added to each concentration, and further cultured for 48 hours. After removing the supernatant, a medium containing 400 μg / mL of 3- (4,5-dimethyl-2-thiazolyl) -2,5-diphenyltetrazolium bromide (MTT) was added to the cells and cultured for about 2 hours. Finally, formazan produced by the opening of the tetrazolium ring was extracted with 2-propanol, the absorbance at 550 nm and 650 nm was measured with a microplate reader, and the cell activation effect was evaluated using the difference between the two measured values. In the evaluation, in addition to the medium containing the sample solution, 1% by mass FBS-added DMEM medium was used as a negative control, and 5% by mass FBS-added DMEM medium was used as a positive control. The evaluation results are shown in Table 1 as relative values with the cell activation effect in the negative control as 100.

Figure 0004970442
Figure 0004970442

表1より明らかなように、キンマ抽出物を添加した培地では、有意な真皮線維芽細胞賦活作用が認められた。キンマ抽出物を0.03〜0.13mg/mLの範囲内で添加したいずれの評価においても、濃度依存的に有意な真皮線維芽細胞賦活作用が認められた。このことから、キンマ抽出物は、優れた真皮線維芽細胞賦活作用を有すること、すなわち抗老化作用を有することが明らかとなった。   As is clear from Table 1, in the medium supplemented with betel extract, a significant dermal fibroblast activation effect was observed. In any evaluation in which the betel extract was added in the range of 0.03 to 0.13 mg / mL, a significant dermal fibroblast activation effect was observed in a concentration-dependent manner. From this, it was clarified that the betel extract has an excellent dermal fibroblast activation effect, that is, an anti-aging effect.

2.ヒト真皮線維芽細胞ATP産生能評価
次に、キンマ抽出物のヒト真皮線維芽細胞ATP産生能評価を以下に示す方法により行った。試料として、製造例1により製造したキンマ抽出物を用いた。
2. Evaluation of human dermal fibroblast ATP production ability Next, the evaluation of human dermal fibroblast ATP production ability of betel extract was performed by the following method. As a sample, the betel extract produced in Production Example 1 was used.

正常ヒト真皮線維芽細胞を1ウェル当たり4.0×10個となるように48穴マイクロプレートに播種した。播種培地には、ダルベッコ改変イーグル培地(DMEM)に1質量%のウシ胎児血清(FBS)を添加したものを用いた。24時間後、試料溶液を各濃度となるように添加した1質量%FBS添加DMEM培地に交換し、さらに24時間培養した。細胞上清を除去して洗浄し、細胞を超音波処理して細胞中のATPを溶出した。その際に細胞内にあるATP分解酵素の溶出を防ぐため、超音波処理に使用するバッファーにATP分解酵素阻害剤(商品名:Cellstein Hoechst 33342)を添加した。作製した細胞溶解液を試験管に分注し、ルシフェラーゼおよびルシフェリン試薬を添加し、コンパクトルミVS501(ヤマト製)によって化学発光を測定した。測定結果を試料溶液無添加の培地を用いたコントロールにおけるATP産生能を100とした相対値にて表2に示す。Normal human dermal fibroblasts were seeded in a 48-well microplate at 4.0 × 10 4 per well. As the seeding medium, Dulbecco's modified Eagle medium (DMEM) to which 1% by mass of fetal bovine serum (FBS) was added was used. After 24 hours, the sample solution was replaced with 1% by mass FBS-added DMEM medium added to each concentration, and further cultured for 24 hours. The cell supernatant was removed and washed, and the cells were sonicated to elute the ATP in the cells. At that time, in order to prevent elution of ATP-degrading enzyme in the cells, an ATP-degrading enzyme inhibitor (trade name: Cellstein Hoechst 33342) was added to the buffer used for sonication. The prepared cell lysate was dispensed into a test tube, luciferase and a luciferin reagent were added, and chemiluminescence was measured with a compact Lumi VS501 (manufactured by Yamato). The measurement results are shown in Table 2 as relative values with the ATP production ability in the control using the medium without addition of the sample solution as 100.

Figure 0004970442
Figure 0004970442

表2より明らかなように、キンマ抽出物を0.5mg/mL含む培地では、有意なヒト真皮線維芽細胞ATP産生能の上昇が認められた。このことから、キンマ抽出物は、優れたヒト真皮線維芽細胞ATP産生能を有すること、すなわち抗老化作用を有することが明らかとなった。   As is clear from Table 2, a significant increase in human dermal fibroblast ATP producing ability was observed in the medium containing 0.5 mg / mL betel extract. This revealed that the betel extract has an excellent ability to produce human dermal fibroblast ATP, that is, has an anti-aging effect.

3.DPPHを使用した抗酸化能評価
次に、キンマ抽出物の抗酸化作用の評価を以下に示す方法にて行った。試料として、製造例1により製造したキンマ抽出物を用いた。
3. Evaluation of antioxidant ability using DPPH Next, the antioxidant activity of betel extract was evaluated by the following method. As a sample, the betel extract produced in Production Example 1 was used.

50質量%エタノール水溶液にて各濃度に希釈した試料溶液を96穴マイクロプレートに100μL添加した。そこへ、0.2mMの濃度になるようにエタノールにて調製した1、1−ジフェニル−2−ピクリルヒドラジル(DPPH)溶液を100μLずつ添加し、よく混合した後、室温、暗所にて10分放置した。その後、DPPHラジカルに由来する516nmの吸光度を測定した。試料溶液が無添加の培地を用いた場合の吸光度を(A1)、試料を添加したときの吸光度を(B1)としたとき、式(1)により算出される値をラジカル消去率とした。評価結果を表3に示す。   100 μL of a sample solution diluted to each concentration with a 50 mass% aqueous ethanol solution was added to a 96-well microplate. To this, 100 μL of 1,1-diphenyl-2-picrylhydrazyl (DPPH) solution prepared in ethanol to a concentration of 0.2 mM was added and mixed well, and then at room temperature in the dark. Left for 10 minutes. Thereafter, the absorbance at 516 nm derived from the DPPH radical was measured. When the absorbance when the sample solution was not added was used as (A1) and the absorbance when the sample was added as (B1), the value calculated by equation (1) was taken as the radical elimination rate. The evaluation results are shown in Table 3.

式(1) {1−(B1)/(A1)}×100(%)   Formula (1) {1- (B1) / (A1)} × 100 (%)

Figure 0004970442
Figure 0004970442

表3より明らかなように、キンマ抽出物はラジカル消去に基づく抗酸化作用を有することが分かった。   As is apparent from Table 3, the betel extract was found to have an antioxidant action based on radical scavenging.

4.SOD様活性評価(スーパーオキサイドアニオン消去能評価)
次に、キンマ抽出物のSOD様活性評価を以下に示す方法により行った。試料として、製造例2により製造したキンマ抽出物を用いた。
4). SOD-like activity evaluation (superoxide anion scavenging ability evaluation)
Next, the SOD-like activity of the betel extract was evaluated by the following method. As a sample, the betel extract produced in Production Example 2 was used.

0.25mM WST-1及び1mM Hypoxanthineを含むHANK’S(+)溶液75μLに、HANK’S(+)溶液にて任意の濃度に調製した試料溶液25μLを添加した。更に、Xanthine Oxidase 25μL(0.0075Units)を添加し、37℃で15分間反応後、450nmの吸光度を測定した。試料溶液に換えてHANK’S(+)のみを添加した場合の吸光度を(A2)、試料溶液を添加した場合の吸光度を(B2)としたとき、式(2)により算出される値をスーパーオキサイドアニオン消去率とした。評価結果を表4に示す。   To 75 μL of the HANK ′S (+) solution containing 0.25 mM WST-1 and 1 mM Hypoxanthine, 25 μL of the sample solution prepared to an arbitrary concentration with the HANK ′S (+) solution was added. Further, 25 μL (0.0075 Units) of Xanthine Oxidase was added, and after reacting at 37 ° C. for 15 minutes, the absorbance at 450 nm was measured. When the absorbance when only HANK'S (+) is added instead of the sample solution is (A2), and the absorbance when the sample solution is added is (B2), the value calculated by equation (2) is the superoxide anion. The elimination rate was used. The evaluation results are shown in Table 4.

式(2) {1−(B2)/(A2)}×100(%)   Formula (2) {1- (B2) / (A2)} × 100 (%)

Figure 0004970442
Figure 0004970442

表4より明らかなように、キンマ抽出物は濃度依存的にスーパーオキサイドアニオン消去に基づく抗酸化作用を有することが分かった。   As is clear from Table 4, it was found that the betel extract has an antioxidant action based on elimination of superoxide anion in a concentration-dependent manner.

5.ヒト表皮メラニン細胞チロシナーゼ活性阻害評価
次に、キンマ抽出物のヒト表皮メラニン細胞チロシナーゼ活性阻害の評価を以下に示す方法により行った。試料として、製造例2により製造したキンマ抽出物を用いた。
5. Evaluation of inhibition of human epidermal melanocyte tyrosinase activity Next, evaluation of inhibition of human epidermal melanocyte tyrosinase activity of betel extract was carried out by the following method. As a sample, the betel extract produced in Production Example 2 was used.

正常ヒト表皮メラニン細胞を1ウェル当たり3.0×10個となるように96穴マイクロプレートに播種した。播種培地には、Medium154Sを用いた。24時間後、試料溶液を各濃度となるように添加したMedium154Sに交換し、さらに48時間培養した。次に1質量%Triton-Xを含有するリン酸緩衝液75μLに交換し、細胞を完全に溶解させ、内50μLを粗酵素液として使用した。粗酵素液に基質となる50μLの0.05質量%L−ドーパ含有リン酸緩衝液を加え、37℃で2時間静置した。マイクロプレートリーダーにて基質添加直後の405nmの吸光度と反応終了時の405nmの吸光度を測定し、式(3)により算出される値をドーパメラニン量とした。式(3)において、基質添加直後の405nmの吸光度を(A3)とし、反応終了時の405nmの吸光度を(B3)とする。Normal human epidermal melanocytes were seeded in a 96-well microplate at 3.0 × 10 4 cells per well. Medium 154S was used as the seeding medium. After 24 hours, the sample solution was replaced with Medium 154S added to each concentration, and further cultured for 48 hours. Next, the solution was exchanged with 75 μL of a phosphate buffer containing 1% by mass of Triton-X to completely lyse the cells, and 50 μL was used as a crude enzyme solution. 50 μL of 0.05% by mass L-dopa-containing phosphate buffer as a substrate was added to the crude enzyme solution, and the mixture was allowed to stand at 37 ° C. for 2 hours. The absorbance at 405 nm immediately after addition of the substrate and the absorbance at 405 nm at the end of the reaction were measured with a microplate reader, and the value calculated by equation (3) was taken as the amount of dopamelanin. In the formula (3), the absorbance at 405 nm immediately after addition of the substrate is (A3), and the absorbance at 405 nm at the end of the reaction is (B3).

式(3) {(B3)―(A3)−2.166}/5.238
そして、PIERCE社製BCA Protein Assay Kitにて各ウェルのタンパク質量を測定し、1μgのタンパク質当たりのドーパメラニン量を求めた。試料溶液が無添加の培地を用いた場合のドーパメラニン量をネガティブコントロールとした。評価結果を表5に示す。
Formula (3) {(B3)-(A3) -2.166} /2.238
Then, the amount of protein in each well was measured using BCA Protein Assay Kit manufactured by PIERCE, and the amount of dopamelanin per 1 μg of protein was determined. The amount of dopamelanin in the case of using a medium with no sample solution added was used as a negative control. The evaluation results are shown in Table 5.

Figure 0004970442
Figure 0004970442

表5より明らかなように、キンマ抽出物には、チロシナーゼ活性を阻害する活性を有することが分かった。すなわち、キンマ抽出物は、美白作用を有することが分かった。   As is clear from Table 5, it was found that the betel extract has an activity to inhibit tyrosinase activity. That is, it was found that the betel extract has a whitening effect.

6.B16マウスメラノーマ細胞を用いたメラニン産生抑制能評価
次に、キンマ抽出物のメラニン産生抑制能の評価を以下に示す方法により行った。試料として、製造例2により製造したキンマ抽出物を用いた。
6). Evaluation of ability to inhibit melanin production using B16 mouse melanoma cells Next, the ability of betel extract to inhibit melanin production was evaluated by the following method. As a sample, the betel extract produced in Production Example 2 was used.

マウスメラノーマ細胞(B16F0ストレイン)を90mmディッシュに1ディッシュあたり18000個となるように播種した。播種培地には、ダルベッコ改変イーグル培地(DMEM)に5質量%のウシ胎児血清(FBS)を添加したものを用いた。24時間後、試料溶液を各濃度となるように添加した5質量%FBS添加DMEM培地に交換し、さらに5日間培養した。培養終了後、トリプシン処理にて細胞をはがし、1.5mLマイクロチューブに移して遠心操作して細胞沈殿物を得た。得られた沈殿物は下記判定基準に基づき、その黒化状況を目視評価した。評価ではネガティブコントロールに5質量%FBS添加DMEM培地、ポジティブコントロールに50mM乳酸ナトリウムを含有する5質量%FBS添加DMEM培地を用いた。これらの目視判定結果をそれぞれ「5」及び「1」として、試料判定の指標とした。目視判定は、下記に示す通り5段階評価した。   Mouse melanoma cells (B16F0 strain) were seeded in a 90 mm dish so that there were 18000 cells per dish. The seeding medium used was Dulbecco's modified Eagle medium (DMEM) supplemented with 5% by weight fetal bovine serum (FBS). After 24 hours, the sample solution was replaced with a 5% by mass FBS-added DMEM medium added to each concentration, and further cultured for 5 days. After completion of the culture, cells were peeled off by trypsin treatment, transferred to a 1.5 mL microtube, and centrifuged to obtain a cell precipitate. The resulting precipitate was visually evaluated for its blackening status based on the following criteria. In the evaluation, a 5% FBS-added DMEM medium containing 5% by mass FBS was used as a negative control, and a 5% FBS-added DMEM medium containing 50 mM sodium lactate was used as a positive control. These visual determination results were “5” and “1”, respectively, and used as an index for sample determination. The visual judgment was evaluated in five stages as shown below.

1:ポジティブコントロールと同程度(ほぼ白)
2:ポジティブコントロールより僅かに黒化する(うすい褐色)
3:ポジティブコントロールとネガティブコントロールの中間(褐色)
4:ネガティブコントロールと比べやや黒化が抑制されている(黒褐色)
5:ネガティブコントロールと同程度(ほぼ黒)
また同時に、沈殿物に組織溶解剤(商品名:Solvable)を添加して煮沸し、室温に戻して分光光度計(分光光度計U-3010、HITACHI製)により500nmの吸光度を測定した。評価結果を表6に示す。
1: Same as positive control (almost white)
2: Slightly blacker than the positive control (light brown)
3: Between positive control and negative control (brown)
4: Slight blackening is suppressed compared to the negative control (blackish brown)
5: Same as negative control (almost black)
At the same time, a tissue solubilizer (trade name: Solvable) was added to the precipitate, boiled, returned to room temperature, and the absorbance at 500 nm was measured with a spectrophotometer (spectrophotometer U-3010, manufactured by HITACHI). The evaluation results are shown in Table 6.

Figure 0004970442
Figure 0004970442

表6の目視評価及び総メラニン量測定から明らかなように、キンマ抽出物には、メラニン産生抑制能を有する、すなわち、美白作用を有することが分かった。   As is clear from the visual evaluation and total melanin amount measurement in Table 6, it was found that the betel extract has a melanin production-inhibiting ability, that is, has a whitening effect.

続いて、本発明に係るキンマ抽出物を配合した皮膚外用剤の処方例を示す。以下の処方例において、各成分の配合量を質量%で表す。   Then, the formulation example of the skin external preparation which mix | blended the betel extract which concerns on this invention is shown. In the following formulation examples, the amount of each component is expressed in mass%.

[処方例1]乳液
(1)スクワラン 10.0(質量%)
(2)メチルフェニルポリシロキサン 4.0
(3)水素添加パーム核油 0.5
(4)水素添加大豆リン脂質 0.1
(5)モノステアリン酸ポリオキシエチレン
ソルビタン(20E.O.) 1.3
(6)モノステアリン酸ソルビタン 1.0
(7)グリセリン 4.0
(8)パラオキシ安息香酸メチル 0.1
(9)カルボキシビニルポリマー 0.15
(10)精製水 53.85
(11)アルギニン(1質量%水溶液) 20.0
(12)キンマ抽出物[製造例1] 5.0
製法:(1)〜(6)の油相成分を80℃にて加熱溶解する。一方(7)〜(10)の水相成分を80℃にて加熱溶解する。これに前記油相成分を攪拌しながら加え、ホモジナイザーにより均一に乳化する。乳化終了後、冷却を開始し、(11)と(12)を順次加え、均一に混合する。
[Formulation Example 1] Emulsion (1) Squalane 10.0 (mass%)
(2) Methylphenylpolysiloxane 4.0
(3) Hydrogenated palm kernel oil 0.5
(4) Hydrogenated soybean phospholipid 0.1
(5) Polystearic acid polyoxyethylene sorbitan (20E.O.) 1.3
(6) Sorbitan monostearate 1.0
(7) Glycerin 4.0
(8) Methyl paraoxybenzoate 0.1
(9) Carboxyvinyl polymer 0.15
(10) Purified water 53.85
(11) Arginine (1% by weight aqueous solution) 20.0
(12) Betel extract [Production Example 1] 5.0
Production method: The oil phase components (1) to (6) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (7) to (10) are dissolved by heating at 80 ° C. The oil phase component is added to this while stirring and uniformly emulsified with a homogenizer. After emulsification, start cooling and add (11) and (12) sequentially and mix uniformly.

[処方例2]化粧水
(1)エタノール 15.0(質量%)
(2)ポリオキシエチレン(40E.O.)硬化ヒマシ油 0.3
(3)香料 0.1
(4)精製水 78.38
(5)クエン酸 0.02
(6)クエン酸ナトリウム 0.1
(7)グリセリン 1.0
(8)ヒドロキシエチルセルロース 0.1
(9)キンマ抽出物[製造例2] 5.0
製法:(1)に(2)及び(3)を溶解する。溶解後、(4)〜(8)を順次添加した後、十分に攪拌し、(9)を加え、均一に混合する。
[Prescription Example 2] Lotion (1) Ethanol 15.0 (mass%)
(2) Polyoxyethylene (40E.O.) hydrogenated castor oil 0.3
(3) Fragrance 0.1
(4) Purified water 78.38
(5) Citric acid 0.02
(6) Sodium citrate 0.1
(7) Glycerin 1.0
(8) Hydroxyethyl cellulose 0.1
(9) Betel extract [Production Example 2] 5.0
Production method: (2) and (3) are dissolved in (1). After dissolution, (4) to (8) are sequentially added, and then sufficiently stirred, (9) is added and mixed uniformly.

[処方例3]クリーム
(1)スクワラン 10.0(質量%)
(2)ステアリン酸 2.0
(3)水素添加パーム核油 0.5
(4)水素添加大豆リン脂質 0.1
(5)セタノール 3.6
(6)親油型モノステアリン酸グリセリン 2.0
(7)グリセリン 10.0
(8)パラオキシ安息香酸メチル 0.1
(9)アルギニン(20質量%水溶液) 15.0
(10)精製水 40.7
(11)カルボキシビニルポリマー(1質量%水溶液) 15.0
(12)キンマ抽出物[製造例1] 1.0
製法:(1)〜(6)の油相成分を80℃にて加熱溶解する。一方(7)〜(10)の水相成分を80℃にて加熱溶解する。これに前記油相成分を攪拌しながら加え、ホモジナイザーにより均一に乳化する。乳化終了後、(11)を加え、冷却を開始し、40℃にて(12)を加え、均一に混合する。
[Prescription Example 3] Cream (1) Squalane 10.0 (mass%)
(2) Stearic acid 2.0
(3) Hydrogenated palm kernel oil 0.5
(4) Hydrogenated soybean phospholipid 0.1
(5) Cetanol 3.6
(6) Lipophilic glyceryl monostearate 2.0
(7) Glycerin 10.0
(8) Methyl paraoxybenzoate 0.1
(9) Arginine (20 mass% aqueous solution) 15.0
(10) Purified water 40.7
(11) Carboxyvinyl polymer (1% by weight aqueous solution) 15.0
(12) Betel extract [Production Example 1] 1.0
Production method: The oil phase components (1) to (6) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (7) to (10) are dissolved by heating at 80 ° C. The oil phase component is added to this while stirring and uniformly emulsified with a homogenizer. After the emulsification is completed, add (11), start cooling, add (12) at 40 ° C., and mix uniformly.

[処方例4]美容液
(1)精製水 27.45(質量%)
(2)グリセリン 10.0
(3)ショ糖脂肪酸エステル 1.3
(4)カルボキシビニルポリマー(1質量%水溶液) 17.5
(5)アルギン酸ナトリウム(1質量%水溶液) 15.0
(6)モノラウリン酸ポリグリセリル 1.0
(7)マカデミアナッツ油脂肪酸フィトステリル 3.0
(8)N-ラウロイル-L-グルタミン酸
ジ(フィトステリル−2−オクチルドデシル) 2.0
(9)硬化パーム油 2.0
(10)スクワラン(オリーブ由来) 1.0
(11)ベヘニルアルコール 0.75
(12)ミツロウ 1.0
(13)ホホバ油 1.0
(14)1、3−ブチレングリコール 10.0
(15)L−アルギニン(10質量%水溶液) 2.0
(16)キンマ抽出物[製造例2] 5.0
製法:(1)〜(6)の水相成分を混合し、75℃にて加熱溶解する。一方、(7)〜(14)の油相成分を混合し、75℃にて加熱溶解する。次いで、上記水相成分に油相成分を添加して予備乳化を行った後、ホモミキサーにて均一に乳化する。乳化終了後に冷却を開始し、50℃にて(15)を加える。さらに40℃まで冷却し、(16)を加え、均一に混合する。
[Formulation Example 4] Cosmetic liquid (1) Purified water 27.45 (mass%)
(2) Glycerin 10.0
(3) Sucrose fatty acid ester 1.3
(4) Carboxyvinyl polymer (1% by weight aqueous solution) 17.5
(5) Sodium alginate (1% by weight aqueous solution) 15.0
(6) Polyglyceryl monolaurate 1.0
(7) Macadamia nut oil fatty acid phytosteryl 3.0
(8) N-lauroyl-L-glutamic acid di (phytosteryl-2-octyldodecyl) 2.0
(9) Hardened palm oil 2.0
(10) Squalane (from olive) 1.0
(11) Behenyl alcohol 0.75
(12) Beeswax 1.0
(13) Jojoba oil 1.0
(14) 1,3-butylene glycol 10.0
(15) L-arginine (10% by mass aqueous solution) 2.0
(16) Betel extract [Production Example 2] 5.0
Production method: The aqueous phase components (1) to (6) are mixed and dissolved by heating at 75 ° C. On the other hand, the oil phase components (7) to (14) are mixed and dissolved by heating at 75 ° C. Next, the oil phase component is added to the aqueous phase component and preliminary emulsification is performed, followed by uniform emulsification with a homomixer. Cooling is started after completion of emulsification, and (15) is added at 50 ° C. Cool further to 40 ° C, add (16) and mix evenly.

[処方例5]水性ジェル
(1)カルボキシビニルポリマー 0.5(質量%)
(2)精製水 86.7
(3)水酸化ナトリウム(10質量%水溶液) 0.5
(4)エタノール 10.0
(5)パラオキシ安息香酸メチル 0.1
(6)香料 0.1
(7)キンマ抽出物[製造例1] 2.0
(8)ポリオキシエチレン(60E.O.)硬化ヒマシ油 0.1
製法:(1)を(2)に加え、均一に攪拌した後、(3)を加える。均一に攪拌した後、(4)に予め溶解した(5)を加える。均一に攪拌した後、予め混合しておいた(6)〜(8)を加え、均一に攪拌混合する。
[Formulation Example 5] Aqueous gel (1) Carboxyvinyl polymer 0.5 (mass%)
(2) Purified water 86.7
(3) Sodium hydroxide (10% by mass aqueous solution) 0.5
(4) Ethanol 10.0
(5) Methyl paraoxybenzoate 0.1
(6) Fragrance 0.1
(7) Betel extract [Production Example 1] 2.0
(8) Polyoxyethylene (60E.O.) hydrogenated castor oil 0.1
Manufacturing method: (1) is added to (2), and after stirring uniformly, (3) is added. After stirring uniformly, (5) previously dissolved in (4) is added. After stirring uniformly, the previously mixed (6) to (8) are added and stirred and mixed uniformly.

[処方例6]クレンジング料
(1)スクワラン 81.0(質量%)
(2)イソステアリン酸ポリオキシエチレングリセリル 15.0
(3)精製水 3.0
(4)キンマ抽出物[製造例2] 1.0
製法:(1)と(2)を均一に溶解する。これに、(3)と(4)を順次加え、均一に混合する。
[Formulation Example 6] Cleansing Fee (1) Squalane 81.0 (mass%)
(2) Polyoxyethylene glyceryl isostearate 15.0
(3) Purified water 3.0
(4) Betel extract [Production Example 2] 1.0
Manufacturing method: (1) and (2) are uniformly dissolved. (3) and (4) are sequentially added to this and mixed uniformly.

[処方例7]洗顔フォーム
(1)ステアリン酸 16.0(質量%)
(2)ミリスチン酸 16.0
(3)親油型モノステアリン酸グリセリン 2.0
(4)グリセリン 20.0
(5)水酸化ナトリウム 7.5
(6)ヤシ油脂肪酸アミドプロピルベタイン 1.0
(7)精製水 36.5
(8)キンマ抽出物[製造例1] 1.0
製法:(1)〜(4)の油相成分を80℃にて加熱溶解する。一方(5)〜(7)の水相成分を80℃にて加熱溶解し、油相成分と均一に混合撹拌する。冷却を開始し、40℃にて(8)を加え、均一に混合する。
[Formulation Example 7] Face-wash foam (1) Stearic acid 16.0 (mass%)
(2) Myristic acid 16.0
(3) Lipophilic glyceryl monostearate 2.0
(4) Glycerin 20.0
(5) Sodium hydroxide 7.5
(6) Palm oil fatty acid amidopropyl betaine 1.0
(7) Purified water 36.5
(8) Betel extract [Production Example 1] 1.0
Production method: The oil phase components (1) to (4) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (5) to (7) are heated and dissolved at 80 ° C., and mixed and stirred uniformly with the oil phase components. Cooling is started, and (8) is added at 40 ° C. and mixed uniformly.

[処方例8]メイクアップベースクリーム
(1)スクワラン 10.0(質量%)
(2)セタノール 2.0
(3)グリセリントリ−2−エチルヘキサン酸エステル 2.5
(4)親油型モノステアリン酸グリセリル 1.0
(5)プロピレングリコール 11.0
(6)ショ糖脂肪酸エステル 1.3
(7)精製水 69.4
(8)酸化チタン 1.0
(9)ベンガラ 0.1
(10)黄酸化鉄 0.4
(11)香料 0.1
(12)キンマ抽出物[製造例2] 1.2
製法:(1)〜(4)の油相成分を混合し、75℃にて加熱溶解する。一方、(5)〜(7)の水相成分を混合し、75℃にて加熱溶解し、これに(8)〜(10)の顔料を加え、ホモミキサーにて均一に分散させる。この水相成分に前記油相成分を加え、ホモミキサーにて乳化する。乳化終了後に冷却を開始し、40℃にて(11)と(12)の成分を加え、均一に混合する。
[Prescription Example 8] Make-up base cream (1) Squalane 10.0 (mass%)
(2) Cetanol 2.0
(3) Glycerin tri-2-ethylhexanoate 2.5
(4) Lipophilic glyceryl monostearate 1.0
(5) Propylene glycol 11.0
(6) Sucrose fatty acid ester 1.3
(7) Purified water 69.4
(8) Titanium oxide 1.0
(9) Bengala 0.1
(10) Yellow iron oxide 0.4
(11) Fragrance 0.1
(12) Betel extract [Production Example 2] 1.2
Production method: The oil phase components (1) to (4) are mixed and dissolved by heating at 75 ° C. On the other hand, the aqueous phase components (5) to (7) are mixed and dissolved by heating at 75 ° C., and the pigments (8) to (10) are added thereto and dispersed uniformly with a homomixer. The oil phase component is added to the water phase component and emulsified with a homomixer. Cooling is started after the emulsification is completed, and the components (11) and (12) are added at 40 ° C. and mixed uniformly.

[処方例9]乳液状ファンデーション
(1)メチルポリシロキサン 2.0(質量%)
(2)スクワラン 5.0
(3)ミリスチン酸オクチルドデシル 5.0
(4)セタノール 1.0
(5)ポリオキシエチレン(20E.O.)
ソルビタンモノステアリン酸エステル 1.3
(6)モノステアリン酸ソルビタン 0.7
(7)1、3−ブチレングリコール 8.0
(8)キサンタンガム 0.1
(9)パラオキシ安息香酸メチル 0.1
(10)精製水 57.4
(11)酸化チタン 9.0
(12)タルク 7.4
(13)ベンガラ 0.5
(14)黄酸化鉄 1.1
(15)黒酸化鉄 0.1
(16)香料 0.1
(17)キンマ抽出物[製造例1] 1.0
製法:(1)〜(6)の油相成分を混合し、75℃にて加熱溶解する。一方、(7)〜(10)の水相成分を混合し、75℃にて加熱溶解し、これに(11)〜(15)の顔料を加え、ホモミキサーにて均一に分散する。油相成分を加え、乳化を行う。乳化終了後に冷却を開始し、40℃にて(16)と(17)の成分を順次加え、均一に混合する。
[Prescription Example 9] Emulsion foundation (1) Methylpolysiloxane 2.0 (mass%)
(2) Squalane 5.0
(3) Octyldodecyl myristate 5.0
(4) Cetanol 1.0
(5) Polyoxyethylene (20E.O.)
Sorbitan monostearate 1.3
(6) Sorbitan monostearate 0.7
(7) 1,3-butylene glycol 8.0
(8) Xanthan gum 0.1
(9) Methyl paraoxybenzoate 0.1
(10) Purified water 57.4
(11) Titanium oxide 9.0
(12) Talc 7.4
(13) Bengala 0.5
(14) Yellow iron oxide 1.1
(15) Black iron oxide 0.1
(16) Fragrance 0.1
(17) Betel extract [Production Example 1] 1.0
Production method: The oil phase components (1) to (6) are mixed and dissolved by heating at 75 ° C. On the other hand, the aqueous phase components (7) to (10) are mixed and dissolved by heating at 75 ° C., and the pigments (11) to (15) are added thereto and uniformly dispersed with a homomixer. Add oil phase ingredients and emulsify. Cooling is started after the emulsification is completed, and components (16) and (17) are sequentially added at 40 ° C. and mixed uniformly.

[処方例10]油中水型エモリエントクリーム
(1)流動パラフィン 30.0(質量%)
(2)マイクロクリスタリンワックス 2.0
(3)ワセリン 5.0
(4)ジグリセリンオレイン酸エステル 5.0
(5)塩化ナトリウム 1.3
(6)塩化カリウム 0.1
(7)プロピレングリコール 3.0
(8)1、3−ブチレングリコール 5.0
(9)パラオキシ安息香酸メチル 0.1
(10)キンマ抽出物[製造例1] 1.0
(11)精製水 47.4
(12)香料 0.1
製法:(5)と(6)を(11)の一部に溶解して50℃とし、50℃に加熱した(4)に撹拌しながら徐々に加える。これを混合した後、70℃にて加熱溶解した(1)〜(3)に均一に分散する。これに(7)〜(10)を(11)の残部に70℃にて加熱溶解したものを撹拌しながら加え、ホモミキサーにて乳化する。乳化終了後に冷却を開始し、40℃にて(12)を加え、均一に混合する。
[Formulation Example 10] Water-in-oil emollient cream (1) Liquid paraffin 30.0 (% by mass)
(2) Microcrystalline wax 2.0
(3) Vaseline 5.0
(4) Diglycerin oleate 5.0
(5) Sodium chloride 1.3
(6) Potassium chloride 0.1
(7) Propylene glycol 3.0
(8) 1,3-butylene glycol 5.0
(9) Methyl paraoxybenzoate 0.1
(10) Betel extract [Production Example 1] 1.0
(11) Purified water 47.4
(12) Fragrance 0.1
Production method: Dissolve (5) and (6) in a part of (11) to 50 ° C., and gradually add to (4) heated to 50 ° C. with stirring. After mixing this, it disperse | distributes uniformly to (1)-(3) heated and melt | dissolved at 70 degreeC. (7) to (10) are added to the remainder of (11) heated and dissolved at 70 ° C. while stirring and emulsified with a homomixer. Cooling is started after completion of emulsification, and (12) is added at 40 ° C. and mixed uniformly.

[処方例11]パック
(1)精製水 58.9(質量%)
(2)ポリビニルアルコール 12.0
(3)エタノール 17.0
(4)グリセリン 5.0
(5)ポリエチレングリコール(平均分子量1000) 2.0
(6)キンマ抽出物[製造例1] 5.0
(7)香料 0.1
製法:(2)と(3)を混合し、80℃に加温した後、80℃に加温した(1)に溶解する。均一に溶解した後、(4)と(5)を加え、攪拌しながら冷却を開始する。40℃まで冷却し、(6)と(7)を加え、均一に混合する。
[Prescription Example 11] Pack (1) Purified water 58.9 (mass%)
(2) Polyvinyl alcohol 12.0
(3) Ethanol 17.0
(4) Glycerin 5.0
(5) Polyethylene glycol (average molecular weight 1000) 2.0
(6) Betel extract [Production Example 1] 5.0
(7) Fragrance 0.1
Production method: (2) and (3) are mixed, heated to 80 ° C, and then dissolved in (1) heated to 80 ° C. After uniformly dissolving, add (4) and (5), and start cooling while stirring. Cool to 40 ° C, add (6) and (7) and mix uniformly.

[処方例12]入浴剤
(1)香料 0.3(質量%)
(2)キンマ抽出物[製造例2] 1.0
(3)炭酸水素ナトリウム 50.0
(4)硫酸ナトリウム 48.7
製法:(1)〜(4)を均一に混合する。
[Prescription Example 12] Bath agent (1) Fragrance 0.3 (% by mass)
(2) Betel extract [Production Example 2] 1.0
(3) Sodium bicarbonate 50.0
(4) Sodium sulfate 48.7
Production method: (1) to (4) are mixed uniformly.

[処方例13]ヘアーワックス
(1)ステアリン酸 3.0(質量%)
(2)マイクロクリスタリンワックス 2.0
(3)セチルアルコール 3.0
(4)高重合メチルポリシロキサン 2.0
(5)メチルポリシロキサン 5.0
(6)ポリ(オキシエチレン・オキシプロピレン)
メチルポリシロキサン共重合体 1.0
(7)パラオキシ安息香酸メチル 0.1
(8)1、3−ブチレングリコール 7.5
(9)アルギニン 0.7
(10)精製水 73.6
(11)キンマ抽出物[製造例1] 2.0
(12)香料 0.1
製法:(1)〜(6)の油相成分を混合し、75℃にて加熱溶解後する。一方、(7)〜(10)の水相成分を75℃にて加熱溶解し、前記油相成分を加え、ホモミキサーにて乳化する。乳化終了後に冷却を開始し、40℃にて(11)と(12)の成分を加え、均一に混合する。
[Prescription Example 13] Hair wax (1) Stearic acid 3.0 (mass%)
(2) Microcrystalline wax 2.0
(3) Cetyl alcohol 3.0
(4) Highly polymerized methylpolysiloxane 2.0
(5) Methylpolysiloxane 5.0
(6) Poly (oxyethylene / oxypropylene)
Methylpolysiloxane copolymer 1.0
(7) Methyl paraoxybenzoate 0.1
(8) 1,3-butylene glycol 7.5
(9) Arginine 0.7
(10) Purified water 73.6
(11) Betel extract [Production Example 1] 2.0
(12) Fragrance 0.1
Production method: The oil phase components (1) to (6) are mixed and heated and dissolved at 75 ° C. On the other hand, the aqueous phase components (7) to (10) are dissolved by heating at 75 ° C., the oil phase component is added, and the mixture is emulsified with a homomixer. Cooling is started after the emulsification is completed, and the components (11) and (12) are added at 40 ° C. and mixed uniformly.

[処方例14]ヘアートニック
(1)エタノール 50.0(質量%)
(2)精製水 48.9
(3)キンマ抽出物[製造例2] 1.0
(4)香料 0.1
製法:(1)〜(4)の成分を混合、均一化する。
[Prescription Example 14] Hairtonic (1) Ethanol 50.0 (mass%)
(2) Purified water 48.9
(3) Betel extract [Production Example 2] 1.0
(4) Fragrance 0.1
Production method: Components (1) to (4) are mixed and homogenized.

[処方例15]飲料
(1)キンマ抽出物[製造例2] 8.0(質量%)
(2)エリスリトール 1.0
(3)クエン酸 0.1
(4)ステビア 0.01
(5)精製水 90.89
製法:(1)〜(5)を均一に混合する。
[Prescription Example 15] Beverage (1) Betel extract [Production Example 2] 8.0 (mass%)
(2) Erythritol 1.0
(3) Citric acid 0.1
(4) Stevia 0.01
(5) Purified water 90.89
Production method: (1) to (5) are mixed uniformly.

次に、キンマ抽出物を配合した処方を用いて使用試験を行い、乾燥による肌荒れについて改善効果を評価した。その際、実施例1として処方例1の乳液を、実施例2として実施例1の製造例1のキンマ抽出物に代えて製造例2のキンマ抽出物を用いた乳液を、比較例1として実施例1のキンマ抽出物に代えて50質量%エタノール水溶液を用いた乳液を、比較例2として実施例1のキンマ抽出物に代えて精製水を用いた乳液を試料として用意した。   Next, a use test was conducted using a prescription formulated with betel extract, and the improvement effect was evaluated for rough skin caused by drying. At that time, the emulsion of Formulation Example 1 as Example 1 and the emulsion using the betel extract of Production Example 2 instead of the betel extract of Production Example 1 of Example 1 as Example 2 were carried out as Comparative Example 1. A milky lotion using a 50% by mass ethanol aqueous solution instead of the betel extract of Example 1 was prepared as a comparative example 2, and an emulsion using purified water instead of the betel extract of Example 1 was prepared as a sample.

各試料について、肌荒れ症状が顕著に認められる30〜50才代の乾燥肌の女性パネラー20名をそれぞれ一群とし、ブラインドにて1週間使用させ、使用前後の皮膚状態の変化を観察して評価した。皮膚症状の指標として、乾燥による肌荒れについて、「改善」、「やや改善」、「変化なし」の三段階で評価し、表7に各評価を得たパネラー数にて示した。   For each sample, 20 female panelists with dry skin in their 30s to 50s whose skin symptom was remarkably recognized were grouped and used blindly for 1 week, and the skin condition before and after use was observed and evaluated. . As an index of skin symptom, rough skin due to dryness was evaluated in three stages of “improved”, “slightly improved”, and “no change”, and Table 7 shows the number of panelists that obtained each evaluation.

Figure 0004970442
Figure 0004970442

表7より、キンマ抽出物を含有しない比較例使用群においては、80%以上のパネラーに改善は認められなかったが、キンマ抽出物を配合した実施例使用群においては、75%以上のパネラーに明確な肌荒れの改善が認められた。このことから、キンマ抽出物は優れた保湿効果を有することが明らかとなった。   From Table 7, in the comparative example use group containing no betel extract, 80% or more of the panelers were not improved, but in the example use group containing the betel extract, 75% or more of the panelers were not improved. A clear improvement in rough skin was observed. This revealed that betel extract has an excellent moisturizing effect.

上記説明から、当業者にとっては、本発明の多くの改良や他の実施形態が明らかである。従って、上記説明は、例示としてのみ解釈されるべきであり、本発明を実行する最良の態様を当業者に教示する目的で提供されたものである。本発明の精神を逸脱することなく、その態様の詳細を実質的に変更できる。   From the foregoing description, many modifications and other embodiments of the present invention are obvious to one skilled in the art. Accordingly, the foregoing description should be construed as illustrative only and is provided for the purpose of teaching those skilled in the art the best mode of carrying out the invention. The details of the embodiments can be varied substantially without departing from the spirit of the invention.

本発明の保湿剤、抗老化剤、美白剤及び抗酸化剤は、医薬品、医薬部外品、皮膚化粧料、毛髪用化粧料又は洗浄料等の皮膚外用剤や飲食品に配合して用いるのに有用である。   The moisturizing agent, anti-aging agent, whitening agent and antioxidant of the present invention are used by blending them with external preparations for skin and foods such as pharmaceuticals, quasi-drugs, skin cosmetics, cosmetics for hair or cleaning products. Useful for.

Claims (1)

キンマの葉の熱水抽出物を有効成分とする美白剤。A whitening agent containing a hot water extract of betel leaves as an active ingredient.
JP2008522268A 2006-06-30 2006-06-30 Whitening agent Active JP4970442B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2006/313120 WO2008001465A1 (en) 2006-06-30 2006-06-30 Moisturizer, antiaging agent, skin whitening agent and antioxidant

Publications (2)

Publication Number Publication Date
JPWO2008001465A1 JPWO2008001465A1 (en) 2009-11-26
JP4970442B2 true JP4970442B2 (en) 2012-07-04

Family

ID=38845240

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008522268A Active JP4970442B2 (en) 2006-06-30 2006-06-30 Whitening agent

Country Status (2)

Country Link
JP (1) JP4970442B2 (en)
WO (1) WO2008001465A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107929191A (en) * 2018-01-10 2018-04-20 广州市聚吉科绿色化学共性技术研究院有限公司 Lightening compositions after one kind is shone

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06336417A (en) * 1993-03-31 1994-12-06 Shiseido Co Ltd Ultraviolet light absorber and external preparation for skin mixed with the same
JPH07238275A (en) * 1994-02-28 1995-09-12 Shiseido Co Ltd Ultraviolet light absorber and skin external preparation containing the same blended therein
JPH09110673A (en) * 1995-10-16 1997-04-28 Kao Corp Bathing agent composition
JP2000290165A (en) * 1999-04-07 2000-10-17 Sansho Seiyaku Co Ltd Skin aging inhibitor and its use
WO2001006995A1 (en) * 1999-07-23 2001-02-01 Cognis Deutschland Gmbh Cosmetic agents containing hydroxychavicol
JP2003226649A (en) * 2002-01-31 2003-08-12 Dai Ichi Seiyaku Co Ltd Agent for preventing and treating insufficiency of melanin production
JP2005263638A (en) * 2004-03-16 2005-09-29 Kanebo Cosmetics Inc Wrinkle remover

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19933857A1 (en) * 1999-07-23 2001-02-01 Cognis Deutschland Gmbh Cosmetics with plant extracts

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06336417A (en) * 1993-03-31 1994-12-06 Shiseido Co Ltd Ultraviolet light absorber and external preparation for skin mixed with the same
JPH07238275A (en) * 1994-02-28 1995-09-12 Shiseido Co Ltd Ultraviolet light absorber and skin external preparation containing the same blended therein
JPH09110673A (en) * 1995-10-16 1997-04-28 Kao Corp Bathing agent composition
JP2000290165A (en) * 1999-04-07 2000-10-17 Sansho Seiyaku Co Ltd Skin aging inhibitor and its use
WO2001006995A1 (en) * 1999-07-23 2001-02-01 Cognis Deutschland Gmbh Cosmetic agents containing hydroxychavicol
JP2003226649A (en) * 2002-01-31 2003-08-12 Dai Ichi Seiyaku Co Ltd Agent for preventing and treating insufficiency of melanin production
JP2005263638A (en) * 2004-03-16 2005-09-29 Kanebo Cosmetics Inc Wrinkle remover

Also Published As

Publication number Publication date
WO2008001465A1 (en) 2008-01-03
JPWO2008001465A1 (en) 2009-11-26

Similar Documents

Publication Publication Date Title
JP5557414B2 (en) Moisturizer, cell activator, and whitening agent
JP5610681B2 (en) Neutral fat accumulation inhibitor
JP5014343B2 (en) Nemagaridake-containing composition, moisturizer, cell activator, whitening agent and antioxidant
JP5312731B2 (en) Topical skin preparation
JP5062980B2 (en) Moisturizer, collagen production promoter, whitening agent, antioxidant, and vascular endothelial growth factor production promoter
JP4689215B2 (en) Moisturizer, cell activator, whitening agent, and collagenase inhibitor
JP4970442B2 (en) Whitening agent
JP4748962B2 (en) Moisturizer, cell activator, whitening agent, and antioxidant
JP2007277100A (en) Humectant, cell activator, dermal fibroblast activator, epidermal cell activator, collagen production accelerator, antioxidant, anti-aging agent, beautifully whitening agent or melanin production inhibitor
JP5247548B2 (en) Moisturizer, anti-aging agent, neutral fat accumulation inhibitor, whitening agent, anti-inflammatory agent, topical skin preparation, oral preparation
JP5465037B2 (en) Anti-aging agent, antioxidant, whitening agent, immunostimulant, external preparation for skin and functional oral composition
JP5025201B2 (en) Moisturizer, anti-aging agent, whitening agent, anti-inflammatory agent, and antioxidant
JP5383001B2 (en) Skin preparations, moisturizers, anti-aging agents, antioxidants, anti-inflammatory agents, whitening agents, and slimming agents
JP4050727B2 (en) Moisturizer, cell activator, whitening agent, antioxidant, and skin external preparation
JP4931452B2 (en) Moisturizer, cell activator, whitening agent, and antioxidant
JP4515425B2 (en) Moisturizer, cell activator, whitening agent, and antioxidant
JP4994684B2 (en) Moisturizer, cell activator, and antioxidant
JP4515423B2 (en) Moisturizer, cell activator, and antioxidant
JP4480366B2 (en) Cell activator, whitening agent, hyaluronic acid production promoter, collagen production promoter, antioxidant, and skin external preparation
JP4291647B2 (en) Cell activator, whitening agent, collagen production promoter, antioxidant, and skin external preparation
JP4869638B2 (en) Cell activator, whitening agent, antioxidant, amylase inhibitor, and humectant
JP4916150B2 (en) Moisturizer, cell activator, antioxidant, and skin external preparation,
JP4936754B2 (en) Moisturizer, cell activator, and collagenase inhibitor
JP5013726B2 (en) Moisturizer, cell activator, antioxidant, and collagenase inhibitor
JP5009544B2 (en) Moisturizer, cell activator, antioxidant, and collagenase inhibitor

Legal Events

Date Code Title Description
RD05 Notification of revocation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7425

Effective date: 20090827

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111011

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20111209

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120306

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120316

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120403

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120404

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150413

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4970442

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250